June 8, 2024

Generic Injectable Market Size to Grow US$ 309.1 Billion By 2030

The global generic injectable market size was valued at US$ 94.3 billion in 2021 and is anticipated to grow US$ 309.1 billion by 2030, registering a CAGR of 14.1% from 2022 to 2030.

Generic Injectable Market Size 2022 To 2030

Key Takeaway:

  • The large molecule type segment has held 69% revenue share in 2021.
  • The small molecule segment accounted 31% market share in 2021.
  • North America region has dominated the market with revenue share of around 46% in 2021.

The generic injectable market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the generic injectable market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the generic injectable report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the generic injectable market have been studied and analysed across many developments.

Report Scope of the Generic Injectable Market

Report Coverage Details
Market Size in 2022 USD 107.6 Billion
Market Size by 2030 USD 309.1 Billion
Growth Rate from 2022 to 2030 CAGR of 14.1%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product Type, Molecular Type, Application, Administration, Distribution Channel, and Geography

Research Approach

The comprehensive report on the global generic injectable market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global generic injectable market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players

  • DR. Reddys Laboratries Ltd
  • Baxter International
  • Mylan N.A
  • Teva Pharmaceuticals
  • Astra Zeneca Plc
  • Sanofi S.A
  • Fresenius Kabi
  • Pfizer Inc
  • Cipla Ltd
  • Merck & Co. Inc
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma Limited
  • Samsung Biologics Co Ltd
  • Biocon
  • Lupin,Ltd
  • Astrazeneca
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals
  • Cosette Pharmaceutical, Inc
  • Johnson & Johnson Services, Inc
  • Sanofi SA
  • Amgen Inc.
  • Bristol- Myers Squibb Company
  • Piramal Pharma Solutions
  • Merck KGaA

Market Segmentations

By Product Type

  • Chemotherapy agents
  • Small molecule antibiotics
  • Vaccines
  • Peptide antibiotics
  • Blood factors
  • Peptide hormone
  • Insulin
  • Cytokines
  • Immunoglobin
  • Monoclonal Antibodies

By Molecular Type

  • Small Molecule
  • Large Molecule

By Application

  • Oncology
  • Diabetes
  • Infectious Diseases
  • Blood Disorders
  • Musculoskeletal Disorders
  • Hormonal Disorders
  • Pain Management
  • CNS Diseases
  • Cardiovascular Diseases

By Administration

  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Drug stores
  • Online pharmacy

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Generic Injectable Market 

5.1. COVID-19 Landscape: Generic Injectable Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Generic Injectable Market, By Product Type

8.1. Generic Injectable Market, by Product Type, 2022-2030

8.1.1. Chemotherapy agents

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Small molecule antibiotics

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Vaccines

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Peptide antibiotics

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Blood factors

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Peptide hormone

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Insulin

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Cytokines

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Immunoglobin

8.1.9.1. Market Revenue and Forecast (2017-2030)

8.1.10. Monoclonal Antibodies

8.1.10.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Generic Injectable Market, By Molecular Type

9.1. Generic Injectable Market, by Molecular Type, 2022-2030

9.1.1. Small Molecule

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Large Molecule

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Generic Injectable Market, By Application 

10.1. Generic Injectable Market, by Application, 2022-2030

10.1.1. Oncology

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Diabetes

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Infectious Diseases

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Blood Disorders

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Musculoskeletal Disorders

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Hormonal Disorders

10.1.6.1. Market Revenue and Forecast (2017-2030)

10.1.7. Pain Management

10.1.7.1. Market Revenue and Forecast (2017-2030)

10.1.8. CNS Diseases

10.1.8.1. Market Revenue and Forecast (2017-2030)

10.1.9. Cardiovascular Diseases

10.1.9.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Generic Injectable Market, By Administration

11.1. Generic Injectable Market, by Administration, 2022-2030

11.1.1. Intravenous (IV)

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Intramuscular (IM)

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Intramuscular (IM)

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Generic Injectable Market, By Distribution Channel

12.1. Generic Injectable Market, by Distribution Channel, 2022-2030

12.1.1. Hospital pharmacy

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Hospital pharmacy

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Drug stores

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Online pharmacy

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Generic Injectable Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.1.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.4. Market Revenue and Forecast, by Administration (2017-2030)

13.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Administration (2017-2030)

13.1.6.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Administration (2017-2030)

13.1.7.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.2.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.4. Market Revenue and Forecast, by Administration (2017-2030)

13.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.7. Market Revenue and Forecast, by Administration (2017-2030)

13.2.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.10. Market Revenue and Forecast, by Administration (2017-2030)

13.2.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Administration (2017-2030)

13.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Administration (2017-2030)

13.2.15. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.3.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.4. Market Revenue and Forecast, by Administration (2017-2030)

13.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Administration (2017-2030)

13.3.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Administration (2017-2030)

13.3.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Administration (2017-2030)

13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Administration (2017-2030)

13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.4.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.4. Market Revenue and Forecast, by Administration (2017-2030)

13.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Administration (2017-2030)

13.4.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Administration (2017-2030)

13.4.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Administration (2017-2030)

13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Administration (2017-2030)

13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.5.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.4. Market Revenue and Forecast, by Administration (2017-2030)

13.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Administration (2017-2030)

13.5.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Molecular Type (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Administration (2017-2030)

13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

Chapter 14. Company Profiles

14.1. DR. Reddys Laboratries Ltd

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Baxter International

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Mylan N.A

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Teva Pharmaceuticals

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Teva Pharmaceuticals

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Sanofi S.A

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Fresenius Kabi

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Pfizer Inc

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Cipla Ltd

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Merck & Co. Inc

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global generic injectable market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for generic injectable are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2180

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *